MARRCH 2020 State of the State Addiction Summit
Friday, January 10, 2020 | 7:00 AM - 4:00 PM
University of Minnesota – Carlson School of Management
Registration Form | View Exhibitor Opportunities
MARRCH Member No cost
Note: Lunch will be provided for all who pre-register. Pre-registration closes Wednesday, January 8 at 12:00 pm.
Carlson School of Management - Honeywell Lecture Hall (L-110)
321 19th Ave S, Minneapolis, MN 55455
19th Ave Ramp Map | 21st Ave Ramp
7:00 AM - 8:00 AM
Registration and Networking
Welcome - Honeywell Lecture Hall (L-110)
Dean Gilbertson, MARRCH Board President; Deborah Wamsley, MARRCH Board Member and University of Minnesota, Resident Faculty Member and Director of Graduate Studies Masters Program in Integrated Behavioral Health and Addiction Studies, College of Continuing and Professional Studies
Featured Elected Officials: MN Senate Finance Chair Julie Rosen & MN House Majority Whip Liz Olson
Keynote: Joel Theisen, RN & Founder/CEO, Lifesprk (LEEDS Collaboration: Case Study in Value Based, Personalized Care)
Data Driven Healthcare: A Cast Study in Patient-Centered/Value-Based Approach
State Agency Panel Discussion
Paul Schnell, DOC Commissioner; Neerja Singh, DHS Deputy Director of Behavioral Health Division; Mark Kinde, MDH Section Manager, Injury and Violence Prevention Section
Preview to Collaborative SUD/MH Data Initiative
John Magnuson, MARRCH Executive Director; Jinny Palen, MACMHP Executive Director; Scott Lloyd, MTM President/Senior National Council Consultant
Dean Gilbertson, MARRCH Board President; John Magnuson, MARRCH Executive Director
MARRCH Legislative Updates
David Aafedt and Andrea Rau , MARRCH Retained Lobbyists (Winthrop & Weinstine); Amy Dellwo and Tim Walsh, MARRCH Government Affairs Committee (GAC) Co-Chairs
Presenting Partners Updates
Jinny Palen, MACMHP; Dr. Emily Burnner, ASAM; Wendy Jones, MRC; JJ Johnson, NAADAC/MNAP, ServeMinnesota; Tani Hemmila, ICSE; Julia Dreier, MCH;, Mark Groves, MCA, MASH, MHLN, CORI; and others
Matthew Michalik, Chief Operation Officer, Premier Biotech; Christiana Finnern, Shareholder, Winthrop & Weinstine, P.A
The importance of incorporating urine drug testing into substance use disorder treatment is widely recognized and acknowledged. Periodic random screening can be effective in planning and reviewing ongoing treatment, supporting completion of treatment goals and justifying the need to make changes to treatment plans. Both providers and clinical laboratories have legal obligations to maintain documentation to support urine drug screens, including signed physician orders and documentation in the treatment record of medical necessity. All too often, claims for urine drug screens are rejected because of a lack of required documentation. In addition, patterns of repeated confirmation testing coupled with a lack of supporting documentation often leads to audits of clinical laboratory claims, resulting in overpayment requests in large dollar amounts. In order to avoid claims processing and payment disruptions that can ultimately lead to delayed or even restricted access to care, it is crucial that both providers and clinical labs understand what their respective obligations are for maintaining documentation supporting the ordering or and medical necessity for drug screens.
Telehealth presentation details coming soon!
Randy McCallum, ADC-T, TTS, DHS Nicotine Policy Program Manager for Substance Use Disorder Treatment Settings
During the session participants will learn about commercial tobacco disparities experienced by people diagnosed with Substance Use Disorders and Minnesota Department of Human Services efforts to provide nicotine treatment for people in treatment settings. Included will be a discussion about the myths regarding tobacco use within the SUD population and the correlating evidence-based realities of nicotine treatment. Participants will also hear about best practices regarding nicotine treatment in SUD treatment settings.
PLUS: SUD Innovation Training – Direct Access/ 1115 Waiver with Neerja Singh, DHS and Nathaniel Dyess, DHS
Rachel Schromen, Estate Planning/ Elder Law Attorney, Owner, Schromen Law, LLC
Estate planning for families who have loved ones that struggle with substance use disorder can be emotionally and mentally difficult. This session will help attendees learn options that exist for families to create an estate plan that can support and provide for a child or loved one struggling with substance use disorder, while also supporting and encouraging his or her recovery. Planning options, such as specialized trusts, will be discussed to educate attendees about what legal mechanisms exist to allow families to plan for the support of their loved one's recovery, rather than enabling their use. This session will also address charitable giving in estate planning, and how this can support the recovery community on a macro level.
Registration deadline: Wednesday, January 8th 12 PM.
To receive a registration refund, less a $5 processing fee, all cancellations must be received via this form by Friday, January 3, 2020 11:59 p.m. U.S. Central Time. No refunds will be granted thereafter. No-shows will not be refunded. Registrations can be transferred to another person within your organization with the same membership status by contacting firstname.lastname@example.org
View full MARRCH event policies here.